Tarsus Pharmaceuticals, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 06/08/2026 | Mar 2026Filed 06/08/2026 | Sep 2025Filed 04/11/2025 | Jun 2025Filed 06/08/2026 | Mar 2025Filed 06/08/2026 | Sep 2024Filed 04/11/2025 | Jun 2024Filed 04/11/2025 | Mar 2024Filed 04/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $174 | $162 | $119 | $103 | $78 | $48 | $41 | $28 | |
| −$19 | −$7 | −$13 | −$20 | −$25 | −$23 | −$33 | −$36 | |
| −$0.43 | −$0.16 | −$0.30 | −$0.48 | −$0.64 | −$0.61 | −$0.88 | −$1.01 | |
| 43 | 43 | 43 | 42 | 39 | 38 | 38 | 35 |
Trend